Medication info
Empagliflozin 10 mg

Empagliflozin 10 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Light yellow, double-sided, convex, film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102110 · Approved 2021.03.05 · Insurance code 647805160

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older patients No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in blood sugar control in adults with type 2 diabetes
  • inability to control blood sugar
  • cardiovascular disease
View approved original text

This medication is an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. If initial blood sugar control is difficult, it can be used as monotherapy, and when self-control is insufficient, it may be administered in combination with other diabetes medications such as metformin. If blood sugar control is inadequate with only metformin or in combination with other drugs, this medication can be added to enhance effectiveness. It can also be used when blood sugar control is insufficient during insulin therapy. Caution is recommended for patients with cardiovascular disease or high risk for type 2 diabetes, so consultation with a professional is advised. This medication effectively improves blood sugar control in patients with type 2 diabetes requiring complex treatment.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older patients No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be administered to certain patients. Firstly, patients with allergic reactions to the active substance or any component of this medication should not use it. Secondly, it is unsuitable for patients with type 1 diabetes or diabetic ketoacidosis. Thirdly, patients with severely impaired renal function, specifically a glomerular filtration rate below 30 mL/min/1.73m2, those with end-stage kidney disease, or those undergoing dialysis should not use this medication. Fourthly, it contains lactose, thus it should not be administered to patients with lactose intolerance, galactose intolerance, or genetic lactase deficiency. This medication should be used with caution in patients with mildly impaired renal function. If the glomerular filtration rate is below 60 mL/min/1.73m2, do not initiate treatment, and if already being treated, dosage adjustment may be necessary. If the glomerular filtration rate falls below 45 mL/min/1.73m2, the medication should be discontinued. This medication is not used in end-stage renal disease or during dialysis, as its efficacy cannot be expected. Patients with heart failure also require caution. It is especially not recommended for patients classified as NYHA class III-IV, and it should be administered with caution to those with mild to moderate heart failure. This medication may increase the risk of hypoglycemia when used with other medications that can cause hypoglycemia, such as insulin or sulfonylureas. Therefore, when used in conjunction with these medications, it may be necessary to reduce the dose of insulin or sulfonylureas. Various adverse reactions can occur while using this medication. The most common side effect is hypoglycemia, particularly increased incidence when used with insulin or sulfonylureas. Also reported are genital infections, urinary tract infections, increased urination, decreased fluid volume, increased serum creatinine, and decreased glomerular filtration rate, decreased blood pressure, dehydration, decreased blood volume, orthostatic hypotension, increased urination, difficulty urinating, interstitial nephritis, thirst, headache, dizziness, anxiety, fatigue, edema, facial swelling, back pain, and glaucoma. Serious side effects include urticaria, angioedema, ketoacidosis, urosepsis, pyelonephritis, perineal necrosis, severe swelling, deep vein thrombosis, acute cholecystitis, autoimmune hepatitis, gallstones, liver abnormalities (jaundice), sudden and severe headaches, cerebrovascular accidents, intracranial aneurysms, seizures, altered consciousness, visual disturbances, paralysis, a significant decrease in urine output, general severe edema, increased blood pressure, severe allergic reactions, severe skin adverse reactions, and severe.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • pruritus
  • rash
  • urticaria
Show 134 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lumbar pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina pectoris
  • Prinzmetal's angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • anxiety
  • acute cholecystitis
  • otalgia
  • position-related vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • upper respiratory tract infection
  • shingles
  • dizziness
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthritis
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • pain from fractures
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nosebleed
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • palpitations
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to keep the storage temperature between 1 and 30 degrees Celsius. Proper storage ensures the medication's effectiveness is maintained safely.

Appearance and packaging

Appearance

Light yellow, double-sided, convex, film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.